Based on 2025 market models, CLOV stock forecast 2025 points toward moderate upside if the company sustains 15% year-over-year membership growth. Broader health insurance sector momentum could act as a catalyst, particularly with favorable CMS reimbursement rates. The general public, mostly comprising of individual investors, collectively holds 59% of Clover Health Investments shares. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions. Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth In CLOV stock forecast 2025, healthcare policy changes remain a key risk factor. Expanded access to Medicare Advantage could support 12–18% premium revenue growth, with stock price implications possibly reaching $4.50 by Q